Läuffer J M, Zimmermann A, Krähenbühl L, Triller J, Baer H U
Department of Visceral and Transplantation Surgery, University of Bern Inselspital, Switzerland.
Cancer. 1996 Dec 1;78(11):2318-27. doi: 10.1002/(sici)1097-0142(19961201)78:11<2318::aid-cncr8>3.0.co;2-i.
Epithelioid hemangioendothelioma (EH) is a rare neoplasm of vascular origin that may develop at different sites, such as in soft tissue, the lungs, or the liver. It usually affects adult females, and its unpredictable malignant potential has a range between benign hemangioma and clearly malignant hemangioendotheliosarcoma.
In the current study, the authors describe 2 patients with primary EH of the liver and review 127 previously published cases found in the literature.
Most patients presented with nonspecific symptoms, such as right upper quadrant abdominal pain or weight loss. The tumors usually presented as multiple nodular lesions involving both lobes of the liver. Overall metastasis rate was 45.1%, with preferential involvement of the lungs and bones. In general, the key to diagnosis was the demonstration of cells containing factor-VIII-related antigen.
EH of the liver is a very rare clinical entity. The primary treatments of choice are radical hepatic resection or orthotopic liver transplantation. The 5-year survival of 55.5% is significantly better than for other hepatic malignancies.
上皮样血管内皮瘤(EH)是一种罕见的血管源性肿瘤,可发生于不同部位,如软组织、肺或肝脏。它通常影响成年女性,其不可预测的恶性潜能介于良性血管瘤和明显恶性的血管内皮肉瘤之间。
在本研究中,作者描述了2例原发性肝EH患者,并回顾了文献中先前发表的127例病例。
大多数患者表现为非特异性症状,如右上腹疼痛或体重减轻。肿瘤通常表现为累及肝脏两叶的多个结节性病变。总体转移率为45.1%,以肺和骨受累为主。一般来说,诊断的关键是证明细胞含有因子VIII相关抗原。
肝EH是一种非常罕见的临床实体。主要的治疗选择是根治性肝切除或原位肝移植。55.5%的5年生存率明显优于其他肝脏恶性肿瘤。